The White House is aiming to spur the production of at least 1 billion coronavirus vaccine doses a year by investing in companies, like Moderna and Pfizer, that make mRNA vaccines. The administration will also fund facilities, equipment, training and staff — an effort to expand capacity, The Post’s Tyler Pager and Dan Diamond report.
